IAN
AZN icon

Integrated Advisors Network’s AstraZeneca AZN Stock Holding History

Integrated Advisors Network’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$458K Buy
2,320
+236
+11% +$45.5K 0.02% 478
2025
Q4 		$383K Sell
2,084
-633
-23% -$111K 0.02% 534
2025
Q3 		$417K Buy
2,717
+640
+31% +$96.9K 0.02% 548
2025
Q2 		$290K Buy
2,077
+131
+7% +$18.4K 0.01% 623
2025
Q1 		$286K Sell
1,946
-1,278
-40% -$185K 0.01% 592
2024
Q4 		$422K Sell
3,224
-18,581
-85% -$2.6M 0.02% 497
2024
Q3 		$3.4M Buy
21,805
+6,930
+47% +$1.12M 0.16% 157
2024
Q2 		$2.32M Buy
14,875
+11,502
+341% +$1.73M 0.12% 188
2024
Q1 		$457K Buy
3,373
+116
+4% +$15.4K 0.02% 484
2023
Q4 		$439K Buy
3,257
+171
+6% +$22.2K 0.02% 472
2023
Q3 		$418K Sell
3,086
-8
-0.3% -$1.09K 0.03% 470
2023
Q2 		$443K Sell
3,094
-136
-4% -$20K 0.03% 463
2023
Q1 		$448K Sell
3,230
-7,198
-69% -$968K 0.03% 462
2022
Q4 		$1.41M Buy
10,428
+435
+4% +$54.6K 0.09% 235
2022
Q3 		$1.1M Sell
9,993
-29,630
-75% -$3.76M 0.07% 254
2022
Q2 		$5.24M Buy
39,623
+998
+3% +$131K 0.34% 75
2022
Q1 		$5.12M Buy
38,625
+903
+2% +$108K 0.3% 77
2021
Q4 		$4.39M Buy
37,722
+329
+0.9% +$38.7K 0.26% 103
2021
Q3 		$4.49M Buy
37,393
+29,513
+375% +$3.44M 0.3% 85
2021
Q2 		$944K Sell
7,880
-1,698
-18% -$186K 0.07% 231
2021
Q1 		$952K Sell
9,578
-14,719
-61% -$1.48M 0.09% 215
2020
Q4 		$2.43M Sell
24,297
-4,562
-16% -$483K 0.27% 108
2020
Q3 		$3.16M Buy
+28,859
New +$3.21M 0.4% 69

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Integrated Advisors Network's AZN Position: Q1 2026 in Review

Integrated Advisors Network increased its AstraZeneca (AZN) stake by 11% in Q1 2026, buying an estimated $45.5K and bringing the position to 2,320 shares worth $458K. The position accounts for 0.02% of the portfolio, ranked #478.

Integrated Advisors Network first reported a position in AZN in Q3 2020 and has held it in 23 quarters since. The position peaked at $5.24M in Q2 2022. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Integrated Advisors Network held 2,320 shares of AstraZeneca worth $458K as of Q1 2026.
  • Integrated Advisors Network bought 236 AstraZeneca shares in Q1 2026, an estimated $45.5K.
  • AstraZeneca made up 0.02% of Integrated Advisors Network's portfolio in Q1 2026, its #478 holding.
  • Integrated Advisors Network first reported a position in AstraZeneca in Q3 2020 and has held it in 23 quarters since.
  • Integrated Advisors Network's AstraZeneca position peaked at $5.24M in Q2 2022.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Integrated Advisors Network's 13F filing for Q1 2026, filed 28 Apr 2026.